NCT02592083View on ClinicalTrials.gov

Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2029

Conditions
Early-Stage Breast CarcinomaHormone Receptor Positive Tumor
Interventions
DRUG

Tamoxifen or Aromatase Inhibitor or Aromatase Inhibitor + goserelin

DRUG

Palbociclib

Trial Locations (1)

17176

Department of Oncology, Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Thomas Hatschek

OTHER